BOND Stock News Total Return ETF Pimco (BOND) 109.02 08/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Total Return ETF Pimco (BOND) 109.02 $BOND

Has Gold Lost its Safe Haven Appeal? - Real Time Insight
Neena Mishra - Zacks Investment Research - Thu Jul 24, 2:24PM CDT
Gold prices are down over the past few weeks even though geopolitical tensions have been rising.

Fed Likely to wind up QE in October - Real Time Insight
Neena Mishra - ZACKS - Wed Jul 09, 3:44PM CDT
With an end-date for QE, the focus now shifts to the timing of the first rate hike.

Top-ranked Corporate Bond ETF in Focus: VCLT - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jun 02, 5:06AM CDT
This top ranked bond ETF has rewarded investors handsomely this year.

What Comes Next as the Bull Market Turns Five? - Real Time Insight
Neena Mishra - Zacks Investment Research - Thu Mar 06, 2:30PM CST
Average and median lengths of bull markets since 1921 are 62 months and 50 months respectively.

Should the Fed Care about Emerging Markets? - Real Time Insight
Neena Mishra - Zacks Investment Research - Wed Feb 19, 3:49PM CST
FOMC members believe that emerging markets' developments do not pose a substantial risk to the US markets.

How to Rebalance Your Portfolio
Dan Caplinger, The Motley Fool - Motley Fool - Sun Feb 09, 12:05PM CST
The Dow Jones Industrials had a great 2013, but the average has gotten off to a terrible start this year. It's important to check your risk level and rebalance your portfolio to avoid unnecessary losses, but what exactly is involved in...

Why Bond Guru Bill Gross Thinks Investors Should Be Careful
Dan Caplinger, The Motley Fool - Motley Fool - Sat Feb 08, 2:05PM CST
The Dow Jones Industrials have gotten out to a terrible start in 2014, dealing investors a tough blow after five straight years of solid gains. But bond legend Bill Gross believes that investors still need to be cautious even after recent...

ETFs Are Not a Strategy
at The Street - Mon Feb 03, 8:33AM CST
Time to think correctly about ETFs: Learn about the sector, then decide on the best ETF.

Fed Remains on Taper Track - Real Time Insight
Neena Mishra - Zacks Investment Research - Wed Jan 29, 2:39PM CST
As expected, the Fed decided to scale down its bond purchases to $65 billion per month.

Should I Buy Bonds After the Taper?
Matt Koppenheffer and David Hanson, The Motley Fool - Motley Fool - Thu Jan 16, 7:00AM CST
With investors still cautious and the Federal Reserve working hard to keep interest rates low, will bonds become more attractive once the Fed exits the market? In this segment of The Motley Fool's financials-focused show, Where the Money Is ,...

What is the Biggest Risk to the Market in 2014? - Real Time Insight
Neena Mishra - Zacks Investment Research - Wed Jan 15, 2:16PM CST
The economic picture is improving and earnings are not bad at all but there are a numbers of threats to the market.

Fed Minutes show Consensus on Tapering - Real Time Insight
Neena Mishra - Zacks Investment Research - Wed Jan 08, 2:57PM CST
Minutes do not provide any new clues about the taper timeline.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BTQ Technologies Calls Investors for Key Quantum Update

Updated Category News Views 177

You know what's stirring the pot over at BTQ Technologies? A shareholder call coming up soon, and boy, it's got 'eye-opening insights' written all over it. We're talkin' Q3 financial results and, likely, a smattering of future plans on the quantum front, folks. Diving into BTQ's Quantum Vision BTQ Technologies Corp. (NASDAQ: BTQ) isn't just another tech firm banging on...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 194

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 137

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 133

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 193

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 197

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 138

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 255

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading